State Ledger
Company profile

Imunon, Inc. CIK 749647

Ticker
IMNN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Lawrenceville, NJ 08648
Fiscal year end
2025 (FY)
Market Data
Close
$1.06
Change
+$0.02
Change %
1.92%
Volume
1,301

IMNN · trading date Oct 12, 2026 · previous close $1.04 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$14.50M
Total assets
$12.29M
Total liabilities
$5.23M
Stockholders' equity
$7.06M
Cash & equivalents
$8.78M
Operating income
-$14.65M
Operating cash flow
-$13.90M
Capital expenditures
$280.6K

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$14.18M
Free cash flow margin
—
Liabilities / assets
42.5%
Equity / assets
57.5%
CapEx / revenue
—
Operating cash flow / net income
0.96×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$14.50M $12.29M $5.23M $7.06M
2024 — -$18.62M $9.72M $5.47M $4.24M
2023 — -$19.51M $21.92M $8.53M $13.39M
2022 $500.0K -$35.90M $43.98M $14.65M $29.33M
2021 $500.0K -$20.77M $74.05M $18.25M $55.80M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Lawrenceville, NJ 08648
997 LENOX DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies